Algo version: 0.98b
Guobang Pharma Ltd. is listed at the SHH Exchange
Guobang Pharma Ltd. [605507.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Guobang Pharma Ltd. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Guobang Pharma Ltd. pays dividends. Last time was Friday 14th of June 2024 where the investors holding the stock on Friday 14th of June 2024 were paid CNY0.30153 per share. Over the last 4 times between 2021 and 2024, Guobang Pharma Ltd. has paid CNY1.60153 with an average of CNY0.4 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Guobang Pharma Ltd. 10 years ago, but if you had invested on Monday 2nd of August 2021 when the price was CNY46.90, you would have made a loss of CNY-26.38 per share or -56.25%

Yes, the average daily trading liquidity for Guobang Pharma Ltd. is CNY3.25 million. You should therefore be able to get in and out of your positions relatively fast.

Guobang Pharma Ltd. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.14, the company's ability to pay off the debt is normal. Guobang Pharma Ltd. has a good net profit margin of 12.17% and should have high tolerances against inflation.

We have calculated the inflation risk for Guobang Pharma Ltd. to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.